Dallah Healthcare Co (SAU:4004) ROCE % : 12.44% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Dallah Healthcare Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dallah Healthcare Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.44%.

Dallah Healthcare Co ROCE % Historical Data

The historical data trend for Dallah Healthcare Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dallah Healthcare Co ROCE % Chart

Dallah Healthcare Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

7.39

5.88

9.35

10.30

11.07

Dallah Healthcare Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															11.87	7.57	10.52	10.83	12.44

Dallah Healthcare Co ROCE % Calculation

Dallah Healthcare Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	504.455	/	( ( (4920.369 - 884.768)	+	(6242.855 - 1162.95) )	/ 2 )
	=	504.455	/	( (4035.601	+	5079.905)	/ 2 )
	=	504.455	/	4557.753
	=	11.07 %

Dallah Healthcare Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	637.972	/	( ( (6242.855 - 1162.95)	+	(6277.121 - 1098.532) )	/ 2 )
	=	637.972	/	( ( 5079.905	+	5178.589 )	/ 2 )
	=	637.972	/	5129.247
	=	12.44 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Dallah Healthcare Co (SAU:4004) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dallah Healthcare Co ROCE % Related Terms

Thank you for viewing the detailed overview of Dallah Healthcare Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dallah Healthcare Co (SAU:4004) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dallah Healthcare Co (SAU:4004) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381

Website

https://www.dallahhealth.com

Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Service/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.

Dallah Healthcare Co (SAU:4004) Headlines

No Headlines